Boundless Bio (BOLD) Cash & Equivalents (2023 - 2026)
Boundless Bio (BOLD) reported Cash & Equivalents of $20.21 million for Q2 2026, up 37.5% from $14.7 million a year earlier and up 15.6% from the prior quarter.
Powered by 
Analysis
Boundless Bio (BOLD) Cash & Equivalents (2023 - 2026) Analysis & Trends
At the end of FY2025, Boundless Bio posted Cash & Equivalents of $17.87 million, down 32.8% from FY2024.
- By year, Cash & Equivalents came in at $26.59 million in FY2024 (+12.2%) and $23.71 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q4 2024.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with an average decline of 3.9%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2024 (growth of 91.8%); the low point was Q3 2025 (a decline of 62.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $17.48 million (Q1 2026), $17.87 million (Q4 2025) and $14.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Boundless Bio | 56.41 Mn | 56.41 Mn | - | 20.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.21 Mn |
| Mar 31, 2026 | 17.48 Mn |
| Dec 31, 2025 | 17.87 Mn |
| Sep 30, 2025 | 14.98 Mn |
| Jun 30, 2025 | 14.70 Mn |
| Mar 31, 2025 | 15.12 Mn |
| Dec 31, 2024 | 26.59 Mn |
| Sep 30, 2024 | 40.21 Mn |
| Jun 30, 2024 | 31.36 Mn |
| Mar 31, 2024 | 25.14 Mn |
| Dec 31, 2023 | 23.71 Mn |
| Sep 30, 2023 | 20.96 Mn |
| Jun 30, 2023 | 41.32 Mn |
| Mar 31, 2023 | 21.06 Mn |
API Access
Boundless Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BOLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BOLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BOLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();